پیوندهای مفید
آمار
| تعداد نشریات | 20 |
| تعداد شمارهها | 1,093 |
| تعداد مقالات | 10,023 |
| تعداد مشاهده مقاله | 27,246,025 |
| تعداد دریافت فایل اصل مقاله | 7,484,764 |
Prevalence of Antiphospholipid Antibodies in Syrian Patients with Thrombosis | ||
| Iranian Journal of Immunology | ||
| مقاله 6، دوره 6، شماره 3، آذر 2009، صفحه 154-159 اصل مقاله (134.13 K) | ||
| نوع مقاله: Original Article | ||
| نویسندگان | ||
| Ali Deeb* 1؛ Said Hamdoun2؛ Khaled Dababo3 | ||
| 1Department of Internal Medicine | ||
| 2Department of Rheumatology | ||
| 3Department of Laboratory in Aleppo University, Aleppo, Syria | ||
| چکیده | ||
| Background: Antiphospholipid antibodies (aPL) are a heterogeneous family of anti-bodies associated with thrombosis and other complications. Objective: To study the prevalence of aPL in patients with thrombosis at Aleppo University Hospitals, Syria. Methods: One hundred and fifty-seven patients with venous and arterial thrombosis and 63 healthy controls were studied. Anticardiolipin antibodies (aCL) and Lupus antico-agulant (LA) were determined. Results: Thirty-four out of 157 (21.7%) patients with thrombosis had some type of aPL. aPL was also found in four healthy subjects (4/63=6.3%). Eighteen patients (11.5%) were positive for LA, 20 (12.7%) for aCL anti-bodies and 4 (2.6%) were positive for more than one aPL. Patients without risk factors for thrombosis and having positive aPL were 23/34 (67.7%). Fourteen out of 78 (17.9%) patients with arterial thrombosis, and 20/79 (25.3%) with venous thrombosis were positive for at least one aPL. Conclusion: Our study showed a significant preva-lence of aPL in patients with thrombosis. It seems that aPL is a risk factor for venous and arterial thrombosis, especially in patients with no conventional risk factors. | ||
| کلیدواژهها | ||
| Antiphospholipid Antibodies؛ Anticardiolipin Antibodies؛ SLE | ||
|
آمار تعداد مشاهده مقاله: 854 تعداد دریافت فایل اصل مقاله: 602 |
||